Intrauterine Contraceptive Device

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 16

Welcome

1
Intrauterine contraceptive
Device
Need for Spacing
Short BTP associated with
• Maternal deaths
• Induced abortion
• Spontaneous miscarriage
• Maternal anemia
• Preterm delivery
• SGA
• Neonatal & infant mortality
• malnutrition
Postpartum IUCD
• A potential answer to satisfactory postpartum contraception
• May be inserted
& at time of LSCS
& Immediate post placental
& Within 48 hrs of delivery
Timing of Postpartum IUCD Insertion
IUCDs can be inserted postpartum
• Right after birth = Postplacental (10 minutes after placenta)
• Soon after birth = Immediate postpartum (< 48 hours after delivery)
• During cesarean section = Intracesarean
• Four or more weeks postpartum
IUCDs should not be inserted between 48 hrs and 4 weeks
6
Postplacental insertion
Long inserter PPIUD
Effectiveness
• Effectiveness: > 99% effective
• 6 – 8 pregnancies per 1 000 women in first year
• Effective immediately upon insertion
• Immediate return to fertility once removed
• Effective for 10+ years
• Can be used as short-term method
IUCDs: Who Should Not Use
(WHO Category 4)

IUCDs should NOT be used if a woman:


• Is pregnant (known or suspected)
• Has unexplained vaginal bleeding
• Has current PID, gonorrhea, or chlamydia
• Has acute purulent (pus-like) discharge
• Has distorted uterine cavity
• Has malignant trophoblast disease
• Has known pelvic tuberculosis
• Has genital tract cancer (cervical or endometrial)
IUCDs: Conditions Requiring
Precautions (WHO Category-3)
• IUDs are not recommended for insertion— unless other methods are
not available or acceptable—if a woman has:
• AIDS, but no antiretroviral therapy or access to care
• A high individual risk of chlamydia and gonococcal infection (partner
has current purulent discharge or STI)
• Ovarian cancer
• Benign trophoblastic disease
MEC and Postpartum IUCD
• The MEC are less specific in this area
• Category 4:
& Immediately after septic abortion
& Immediately after puerperal sepsis
& Unresolved postpartum hemorrhage (not mentioned in MEC)
• Category 3:
& Between 48 hours and 4 weeks
& Prolonged ROM > 18 hours (not mentioned in MEC)
• Category 2: no conditions
• Category 1:
& Immediate post placental or postpartum <48 hours
& > 4 weeks
The Most Likely Precautions

Therefore, in the most typical situation,


providers Should watch out for:
• Unresolved hemorrhage (still having
worrisome bleeding)
• Chorioamnionitis/puerperal sepsis l
Rupture of membranes >18 hours
(potential for infection)
• Recent purulent cervicitis
Postpartum Insertion
Advantages and Limitations
Advantages:
Limitations:
• Changes in monthly bleeding pattern
• Very effective, reversible, long-
term method • Slightly higher rate of expulsion
• Safe, convenient and no increased & 8 – 14%
risk perforation or infection & with good technique: 4– 5%
• Does not affect the quantity or • Meaning 86-92% retention
quality of breast milk • Requires special training of providers
• Greater coverage of population
IUCD and Anemia
• Monthly menstrual bleeding increases slightly with the IUCD, especially
in first 3 months
• Blood loss which results in anemia is rare
• Therefore, it is safe to provide an anemic woman with an IUCD (WHO
MEC Category 2)
• If a woman is anemic and has the IUCD in place, continue to treat
anemia with iron/folate
Thanks

16

You might also like